Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Natural History Study of CEP290-Related Retinal Degeneration

NCT03396042 is registered in ClinicalTrials.gov with Editas Medicine, Inc. as lead sponsor.

NCT NCT03396042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03396042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Natural History Study of CEP290-Related Retinal Degeneration
Lead sponsor
Editas Medicine, Inc.
Phase
Observational
Overall status
Completed
Start date
December 17, 2017
Completion date
May 6, 2022
Enrollment
26 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

blindness, eye diseases, eye diseases, hereditary, eye disorders congenital, leber congenital amaurosis 10, retinal degeneration, retinal disease, vision disorders